Axsome Therapeutics, Inc.
AXSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001579428
In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 505 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Axsome Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 245
- +20 vs. Q3 2023
- Shares held
- 38.6M
- +779.1K (+2.1%) vs. Q3 2023
- Total value
- $3.07B
- +$428.7M (+16.2%) vs. Q3 2023
- New holders
- 44
- 70 more added
- Sold out
- 24
- 87 more reduced
2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AXSM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 505 | $9.34B |
| Q1 2026 | 410 | $6.41B |
| Q4 2025 | 399 | $6.86B |
| Q3 2025 | 355 | $4.51B |
| Q2 2025 | 348 | $3.95B |
| Q1 2025 | 353 | $4.37B |
| Q4 2024 | 292 | $3.15B |
| Q3 2024 | 280 | $3.48B |
| Q2 2024 | 257 | $3.28B |
| Q1 2024 | 259 | $3.09B |
| Q4 2023 | 245 | $3.07B |
| Q3 2023 | 227 | $2.65B |
| Q2 2023 | 231 | $2.61B |
| Q1 2023 | 197 | $1.97B |
| Q4 2022 | 219 | $2.32B |
| Q3 2022 | 188 | $1.15B |
| Q2 2022 | 174 | $826.7M |
| Q1 2022 | 175 | $787.4M |
| Q4 2021 | 167 | $704.2M |
| Q3 2021 | 171 | $627.3M |
| Q2 2021 | 176 | $1.51B |
| Q1 2021 | 184 | $1.31B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Axsome Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Altium Capital Management LP | 138,000 | $11.0M | 7.57% | +46,000+50.0% | Added |
| Iridian Asset Management LLC | 138,337 | $11.0M | 2.00% | −6,696−4.6% | Reduced |
| US Bancorp | 143,424 | $11.4M | 0.02% | +4,653+3.4% | Added |
| Price T Rowe Associates Inc | 146,557 | $11.7M | 0.00% | +123,949+548.3% | Added |
| Checkpoint Capital L.P. | 155,346 | $12.4M | 8.63% | +155,346 | New |
| Ghost Tree Capital, LLC | 165,000 | $13.1M | 7.56% | +55,000+50.0% | Added |
| Bank of New York Mellon Corp | 166,293 | $13.2M | 0.00% | −1,713−1.0% | Reduced |
| Bank of America Corp | 176,167 | $14.0M | 0.00% | +139,041+374.5% | Added |
| JPMorgan Chase & Co | 189,905 | $15.1M | 0.00% | +17,449+10.1% | Added |
| Barclays PLC | 191,862 | $15.3M | 0.01% | +175,052+1,041.4% | Added |
| Norges Bank | 195,123 | $15.5M | 0.00% | −15,099−7.2% | Reduced |
| Goldman Sachs Group Inc | 205,815 | $16.4M | 0.00% | +46,566+29.2% | Added |
| Nuveen Asset Management, LLC | 234,646 | $18.7M | 0.01% | +18,089+8.4% | Added |
| Wellington Management Group LLP | 239,819 | $19.1M | 0.00% | +2,265+1.0% | Added |
| Driehaus Capital Management LLC | 265,842 | $21.2M | 0.25% | +16,953+6.8% | Added |
| First Turn Management, LLC | 295,428 | $23.5M | 3.38% | +295,428 | New |
| Charles Schwab Investment Management Inc | 295,701 | $23.5M | 0.01% | +5,830+2.0% | Added |
| Tang Capital Management LLC | 320,000 | $25.5M | 2.35% | 00.0% | Unchanged |
| Northern Trust Corp | 343,308 | $27.3M | 0.00% | −5,749−1.6% | Reduced |
| Eventide Asset Management, LLC | 346,712 | $27.6M | 0.45% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 365,000 | $29.1M | 0.06% | +40,000+12.3% | Added |
| Hood River Capital Management LLC | 392,753 | $31.3M | 0.86% | +9,477+2.5% | Added |
| Boxer Capital, LLC | 400,000 | $31.8M | 1.59% | 00.0% | Unchanged |
| Avidity Partners Management LP | 459,400 | $36.6M | 1.40% | +162,600+54.8% | Added |
| PFM Health Sciences, LP | 467,427 | $37.2M | 2.23% | −55,783−10.7% | Reduced |
| Woodline Partners LP | 562,163 | $44.7M | 0.49% | +110,056+24.3% | Added |
| Jefferies Financial Group Inc. | 563,335 | $44.8M | 0.70% | +10,140+1.8% | Added |
| Morgan Stanley | 619,379 | $49.3M | 0.00% | +320,958+107.6% | Added |
| Bellevue Group AG | 635,372 | $50.6M | 0.77% | +3,885+0.6% | Added |
| Pictet Asset Management Holding SA | 698,932 | $55.6M | 0.06% | +52,503+8.1% | Added |
| Alethea Capital Management, LLC | 752,044 | $59.9M | 69.06% | −6,750−0.9% | Reduced |
| Geode Capital Management, LLC | 822,304 | $65.5M | 0.01% | +43,809+5.6% | Added |
| Point72 Asset Management, L.P. | 837,201 | $66.6M | 0.20% | +305,264+57.4% | Added |
| FMR LLC | 882,027 | $70.2M | 0.01% | −976,529−52.5% | Reduced |
| Millennium Management LLC | 909,965 | $72.4M | 0.07% | +406,923+80.9% | Added |
| State Street Corp | 924,190 | $73.6M | 0.00% | +56,543+6.5% | Added |
| Deep Track Capital, LP | 1,000,000 | $79.6M | 2.79% | −140,745−12.3% | Reduced |
| Ra Capital Management, L.P. | 1,000,000 | $79.6M | 1.24% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,038,019 | $82.6M | 1.85% | +556,370+115.5% | Added |
| Citadel Advisors LLC | 1,089,085 | $86.7M | 0.09% | −206,539−15.9% | Reduced |
| BVF Inc | 1,981,100 | $157.7M | 3.95% | −150,000−7.0% | Reduced |
| Fairmount Funds Management LLC | 2,360,077 | $187.8M | 19.85% | +18,839+0.8% | Added |
| BlackRock Inc. | 3,239,746 | $257.9M | 0.01% | +305,256+10.4% | Added |
| Vanguard Group Inc | 3,696,766 | $294.2M | 0.01% | −32,360−0.9% | Reduced |
| RTW Investments, LP | 4,489,596 | $357.3M | 5.58% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −237,500−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −103,721−100.0% | Sold out |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −80,368−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −59,248−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −17,450−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,686−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −13,255−100.0% | Sold out |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −11,254−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −9,800−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −8,992−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −5,250−100.0% | Sold out |
| Old National Bancorp | 0 | $0 | 0.00% | −4,550−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −4,388−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −4,040−100.0% | Sold out |
| First National Trust Co | 0 | $0 | 0.00% | −3,412−100.0% | Sold out |
| Kaizen Financial Strategies | 0 | $0 | 0.00% | −3,200−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −2,912−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −2,881−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −2,864−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −1,745−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −65−100.0% | Sold out |
| Psagot Value Holdings Ltd. / (Israel) | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |
| Innovis Asset Management LLC | – | – | – | – | Not filed |